Health & Research Goals
Beyond Health LabIsolated Peptide
Tesofensine
Classification
Research Peptide
USA
COA
$$$Cost
Vial Size
5 mg
Available in:5mg
Frequency
—
Cycle
—
Storage
—
Half-Life~8 days
Onset2-4 weeks
RouteOral capsule
EvidenceModerate (Phase 2/3 trials)
MonitoringBlood pressure, heart rate, weight
Primary Description
Key Benefits
- Appetite suppression
- Increased metabolism
- Weight loss
Proposed Mechanisms of Action
Proposed mechanisms based on available research
Research Evidence & Clinical Data
Review of available research evidence and clinical data
Scientific References
- 1.
- 2.Randomized controlled trial of Tesomet for weight loss in hypothalamic obesityEur J Endocrinol2022
- 3.The effect of tesofensine on appetite sensationsObesity (Silver Spring)2012
Safety Profile
Common Side Effects
- Dry mouth
- Insomnia
- Increased heart rate
Contraindications
- Cardiovascular disease
- Hypertension
- MAOIs
Research Protocols
Dosing protocols based on available research data
Dosing Protocols
Monitoring & Risk Management
Monitoring guidelines based on available data
No Specific Monitoring Protocol
No structured monitoring data is available for this compound. Always consult a healthcare professional before use.